Capricor therapeutics, inc. (CAPR)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-7,207

-7,641

-9,432

-11,961

-14,038

-15,191

373

1,775

2,426

2,431

-14,391

-16,990

-18,207

-18,806

-17,634

-15,213

-13,647

-12,857

-11,439

-10,071

-8,482

-6,216

-8,593

-8,594

-8,685

-8,891

-4,967

-3,988

-2,716

-2,071

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Sub-award payable, related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Accrued royalties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

Accrued interest

-

-

-

-

-

-

-

-

-

398

421

412

383

344

302

265

250

246

245

243

236

200

164

128

79

58

0

0

0

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-1,367

-2,050

-2,734

-2,962

-3,190

-3,417

-3,645

-3,645

-3,776

-3,906

-4,036

-4,166

8,333

0

0

0

-

-

-

-

-

-

-

-

Proceeds from sale of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Note discount arising from beneficial conversion feature

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Loss on disposal of fixed asset

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Gain on sale of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Depreciation and amortization

161

171

172

171

166

157

148

141

139

144

143

136

132

125

122

124

117

110

93

76

60

41

34

29

27

26

35

30

24

20

0

0

0

Warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Write-off of intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Common stock issued for services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Impairment of goodwill

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Stock-based compensation

765

700

963

1,168

1,491

1,725

1,748

1,745

1,696

1,710

1,760

1,887

2,143

1,962

1,890

1,602

1,291

1,573

1,331

1,219

984

496

433

349

306

263

204

184

201

332

0

0

0

Change in assets - (increase) decrease:
Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,977

-3,699

-3,778

1,492

1,575

631

4,378

40

1,401

0

0

0

-

-

-

-

Receivables

-3

-116

-71

-143

-184

-139

-88

-25

109

121

197

94

-106

11

-340

-161

-442

-148

142

380

746

360

136

-358

-437

-767

0

0

0

-

-

-

-

Interest receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

Prepaid expenses and other current assets

8

-152

-297

-12

-96

223

236

148

124

158

72

0

76

132

25

108

118

-24

-12

7

32

12

35

46

91

136

0

0

0

-

-

-

-

Other assets

-25

-32

-32

-78

-24

55

95

145

96

34

-0

-0

-9

-8

-71

-7

1

14

77

14

43

29

27

34

5

5

0

0

0

-

-

-

-

Change in liabilities - increase (decrease):
Accounts payable and accrued expenses

-166

-273

-796

314

54

-347

479

-970

-1,097

-1,542

-2,655

-745

-718

508

1,611

244

478

831

583

853

1,094

70

714

629

929

1,072

0

0

0

-

-

-

-

Accounts payable and accrued expenses, related party

-9

-84

-119

-67

-31

-68

32

-197

-40

-314

-599

-235

-361

136

119

8

-161

-81

278

38

151

9

23

203

108

184

0

0

0

-

-

-

-

Noncash interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Prepaid expenses and other current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Other non-current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Accrued expenses and other current liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Due to related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

NET CASH USED IN OPERATING ACTIVITIES

-6,431

-6,821

-8,807

-10,138

-12,052

-13,862

-12,758

-12,966

-12,972

-14,230

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

CASH FLOWS FROM INVESTING ACTIVITIES:
Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

-

-

-

-

NET CASH USED IN OPERATING ACTIVITIES

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-15,952

-12,946

-10,817

-9,320

-8,298

-12,436

958

3,284

994

6,375

-6,144

0

0

0

-

-

-

-

Purchase of marketable securities

12,117

6,002

3,026

9,023

15,024

18,011

22,984

21,985

17,991

18,986

23,990

21,496

19,488

17,997

5,011

5,007

5,007

17,989

17,987

15,487

15,260

0

0

0

411

226

0

0

0

-

-

-

-

Proceeds from sales and maturities of marketable securities

12,117

3,000

9,000

15,000

21,000

23,000

22,000

20,000

21,000

24,000

21,500

20,000

13,000

13,000

15,500

18,000

18,000

10,000

5,326

326

99

327

1,295

2,427

3,853

4,114

0

0

0

-

-

-

-

Purchases of property and equipment

-

-

-

-

-

316

332

202

215

32

137

132

149

191

91

154

148

129

140

96

97

162

150

135

145

56

65

50

16

13

0

0

0

Payments for leasehold improvements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

21

21

9

33

23

0

0

0

-

-

-

-

-

-

-

-

Other investing activities, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Proceeds from sale of assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Payments for patents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

NET CASH PROVIDED BY INVESTING ACTIVITIES

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12,824

12,832

-8,140

-12,757

-15,243

-15,289

141

0

0

0

-

-

-

-

-

-

-

-

Proceeds from reverse merger

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Payments for patents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

NET CASH PROVIDED BY INVESTING ACTIVITIES

0

-3,002

5,989

5,846

5,844

4,671

-1,316

-2,188

2,792

4,981

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Repayment of notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Proceeds from exercise of stock options and warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Net proceeds from sale of common stock

12,201

9,174

5,076

3,541

5,774

6,714

8,971

12,540

13,446

11,073

8,303

13,616

9,935

13,864

13,864

3,929

3,929

16,446

16,446

16,446

16,446

0

0

0

0

-

-

-

-

-

0

0

0

Proceeds from exercise of pre-funded common stock warrants and warrants

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from loan payable

-

-

-

-

-

-

-

-

-

500

250

2,000

3,750

4,750

4,750

3,000

1,000

0

0

0

0

-

-

-

-

3,925

0

0

0

-

-

-

-

Proceeds from stock options

-

-

-

-

-

139

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from stock awards, warrants, and options

-

-

-

-

-

-

-

-

-

-

-

-

-

13

13

11

11

45

45

37

38

4

0

0

0

-

-

-

-

-

-

-

-

Proceeds from stock option exercises

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Costs related to the issuance of preferred stock and warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

NET CASH PROVIDED BY FINANCING ACTIVITIES

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Proceeds from sale of common stock in private placement, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

NET CASH PROVIDED BY FINANCING ACTIVITIES

12,293

9,177

5,079

3,544

5,774

6,853

9,367

12,935

14,092

11,579

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

NET CASH PROVIDED BY FINANCING ACTIVITIES

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,940

4,941

16,491

16,491

16,998

21,685

5,205

0

0

0

-

-

-

-

-

-

-

-

NET DECREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH

5,862

-645

2,260

-746

-433

-2,337

-4,707

-2,218

3,912

2,330

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,827

-2,466

-5,587

-6,543

-6,039

6,305

9,529

10,964

12,696

1,559

-517

-670

-664

-1,380

0

0

0

SUPPLEMENTAL DISCLOSURES:
Interest paid in cash

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest paid in cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

2

2

2

2

0

0

0

0

0

0

0

0

0

0

0

0

0

Income taxes paid in cash

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

-

Warrants issued in satisfaction of accrued liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Warrants issued to placement agent and investors in connection with private placements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Warrants issued to investors in connection with registered direct offering

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Conversion of notes payable and interest to common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Common shares of SMI issued in reverse merger transaction

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0